Wilms’ tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression

(2017) R Gupta et al.   ONCOGENE

WT1 is involved in the Akt-JNK pathway dependent autophagy through directly regulating Gas1 expression in human osteosarcoma cells

(2016) Hao Mo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Wilms tumor protein 1 (WT1) — Not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma

(2016) Eliane Tabea Taube et al.   GYNECOLOGIC ONCOLOGY

Decreasing the ratio of matriptase/HAI-1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer

(2016) Pengming Sun et al.   Molecular Medicine Reports

Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis

(2016) Geum-A. Lee et al.   Toxins

Role of EMT in Metastasis and Therapy Resistance

(2016) Bethany Smith et al.   Journal of Clinical Medicine

Research Progress of MicroRNA in Early Detection of Ovarian Cancer

(2015) Cong-Jian Xu et al.   CHINESE MEDICAL JOURNAL

Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China

(2015) Fang Ye et al.   FASEB JOURNAL

In vivo tumor growth of high-grade serous ovarian cancer cell lines

(2015) Anirban K. Mitra et al.   GYNECOLOGIC ONCOLOGY

Mechanisms of transcriptional regulation by WT1 (Wilms’ tumour 1)

(2015) Eneda Toska et al.   BIOCHEMICAL JOURNAL

Role of the Wilms’ tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms

(2014) YAN LI et al.   ONCOLOGY REPORTS

Correction: Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

(2014)   PLoS One

Wilms’ Tumor Gene 1 (WT1) Silencing Inhibits Proliferation of Malignant Peripheral Nerve Sheath Tumor sNF96.2 Cell Line

(2014) Rosalba Parenti et al.   PLoS One

Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells

(2014) Eun Kim et al.   RESPIRATORY RESEARCH

WT1 Promotes Invasion of NSCLC via Suppression of CDH1

(2013) Chen Wu et al.   Journal of Thoracic Oncology

The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells

(2013) Adina Brett et al.   Molecular Cancer

Fibroblast Growth Factor 2 Induces E-Cadherin Down-Regulation via PI3K/Akt/mTOR and MAPK/ERK Signaling in Ovarian Cancer Cells

(2013) Man-Tat Lau et al.   PLoS One

High Wilms’ tumor 1 mRNA expression correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer

(2012) XIAO-WEI QI et al.   ONCOLOGY REPORTS

The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis

(2012) You-Ying Chau et al.   TRENDS IN GENETICS

Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models

(2010) Silvestre Vicent et al.   JOURNAL OF CLINICAL INVESTIGATION

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

(2010) Qianghua Hu et al.   JOURNAL OF CLINICAL INVESTIGATION

Epithelial–mesenchymal transition in ovarian cancer

(2009) Daniele Vergara et al.   CANCER LETTERS

Biomarkers for epithelial-mesenchymal transitions

(2009) Michael Zeisberg et al.   JOURNAL OF CLINICAL INVESTIGATION

Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin

(2009) Ofelia M Martínez-Estrada et al.   NATURE GENETICS

Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion

(2008) Maria V. Barbolina et al.   CANCER

WT1 Induction of Mitogen-Activated Protein Kinase Phosphatase 3 Represents a Novel Mechanism of Growth Suppression

(2008) D. J. Morrison et al.   MOLECULAR CANCER RESEARCH